{{#subject}}Vaccine maker to use technology behind COVID-19 shot to target malaria{{/subject}}Vaccine maker to use technology behind COVID-19 shot to target malaria

BERLIN (AP) — Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria. The Germany-based company, which developed the first widely approved coronavirus shot together with U.S. partner Pfizer, aims to begin clinical trials for a “safe and highly effective malaria vaccine” by the end […] Read more